Acute macular neuroretinopathy following COVID-19 infection

N Z Med J. 2022 Oct 7;135(1563):105-107. doi: 10.26635/6965.5835.

Abstract

COVID-19 is a global pandemic with over 600 million cases worldwide and over 1.7 million cases in New Zealand to date. The most recent spread of Omicron variant saw widespread infection across the country that was unable to be controlled like the initial Alpha or Delta variants. There is limited information on ocular complications of COVID 19. In our case, there was a close relationship between time of COVID-19 infection and acute visual changes including ongoing scotomas (blind spots). This report explores a case of a young female with positive visual phenomena following COVID-19 infection, with the diagnosis of acute macula neuroretinopathy.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • COVID-19*
  • Female
  • Humans
  • Macula Lutea*
  • New Zealand
  • Retinal Diseases* / diagnosis
  • Retinal Diseases* / etiology
  • SARS-CoV-2
  • White Dot Syndromes*

Supplementary concepts

  • SARS-CoV-2 variants